Effect of Risk Disclosures on Prescription Drug Advertising: The Moderating Role of Need-For-Cognition, Involvement, and Dogmatism
5 Angebote vergleichen
| Preise | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|
| Schnitt | € 52,95 | € 45,65 | € 45,65 | € 54,88 |
| Nachfrage |
1
Effect of Risk Disclosures on Prescription Drug Advertising: The Moderating Role of Need-For-Cognition, Involvement, and Dogmatism (2009)
EN PB NWISBN: 9783639197556 bzw. 3639197550, in Englisch, 68 Seiten, VDM Verlag, Taschenbuch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, Usually ships in 24 hours.
Von Händler/Antiquariat, Amazon.com.
In February 2004, the Food and Drug Administration (FDA) issued draft guidelines for presenting risk information in prescription drug advertisements. The effectiveness of the proposed formats is unknown. This work involved an experimental examination of the effects of three FDA-recommended risk disclosure options on responses to the ad. The findings suggest that each of the recommended risk disclosure options contain sufficient information for evaluating prescription drug advertisements. Of the three versions tested, the ads with least amount of information were the most desirable. Results also revealed that involvement influenced ad credibility, attitude-toward-the-ad, and brand interest, while drug type influenced attitude-toward-the-ad, brand interest, and purchase intention. Ad version influenced purchase intention indirectly through brand interest. This book, therefore, provides new insights to drug advertisers, advertising researchers, and policymakers on the effectiveness of risk disclosure options in prescription drug advertising. Paperback, Label: VDM Verlag, VDM Verlag, Produktgruppe: Book, Publiziert: 2009-09-18, Studio: VDM Verlag, Verkaufsrang: 14436984.
Von Händler/Antiquariat, Amazon.com.
In February 2004, the Food and Drug Administration (FDA) issued draft guidelines for presenting risk information in prescription drug advertisements. The effectiveness of the proposed formats is unknown. This work involved an experimental examination of the effects of three FDA-recommended risk disclosure options on responses to the ad. The findings suggest that each of the recommended risk disclosure options contain sufficient information for evaluating prescription drug advertisements. Of the three versions tested, the ads with least amount of information were the most desirable. Results also revealed that involvement influenced ad credibility, attitude-toward-the-ad, and brand interest, while drug type influenced attitude-toward-the-ad, brand interest, and purchase intention. Ad version influenced purchase intention indirectly through brand interest. This book, therefore, provides new insights to drug advertisers, advertising researchers, and policymakers on the effectiveness of risk disclosure options in prescription drug advertising. Paperback, Label: VDM Verlag, VDM Verlag, Produktgruppe: Book, Publiziert: 2009-09-18, Studio: VDM Verlag, Verkaufsrang: 14436984.
2
Symbolbild
Effect of Risk Disclosures on Prescription Drug Advertising (2009)
DE PB NW RPISBN: 9783639197556 bzw. 3639197550, in Deutsch, VDM Verlag Dr. Müller, Saarbrücken, Deutschland, Taschenbuch, neu, Nachdruck.
Von Händler/Antiquariat, English-Book-Service - A Fine Choice [1048135], Waldshut-Tiengen, Germany.
This item is printed on demand for shipment within 3 working days.
This item is printed on demand for shipment within 3 working days.
3
Effect of Risk Disclosures on Prescription Drug Advertising: The Moderating Role of Need-For-Cognition, Involvement, and Dogmatism (2009)
EN PB NWISBN: 9783639197556 bzw. 3639197550, in Englisch, 68 Seiten, VDM Verlag, Taschenbuch, neu.
Lieferung aus: Deutschland, Gewöhnlich versandfertig in 24 Stunden.
Von Händler/Antiquariat, Amazon.de.
Taschenbuch, Label: VDM Verlag, VDM Verlag, Produktgruppe: Book, Publiziert: 2009-09-18, Studio: VDM Verlag.
Von Händler/Antiquariat, Amazon.de.
Taschenbuch, Label: VDM Verlag, VDM Verlag, Produktgruppe: Book, Publiziert: 2009-09-18, Studio: VDM Verlag.
4
Effect of Risk Disclosures on Prescription Drug Advertising: The Moderating Role of Need-For-Cognition, Involvement, and Dogmatism (2009)
EN NWISBN: 9783639197556 bzw. 3639197550, in Englisch, 68 Seiten, VDM Verlag, neu.
Lieferung aus: Italien, Generalmente spedito in 24 ore.
Von Händler/Antiquariat, Amazon.it.
Copertina flessibile, Label: VDM Verlag, VDM Verlag, Produktgruppe: Libro, Publiziert: 2009-09-18, Studio: VDM Verlag.
Von Händler/Antiquariat, Amazon.it.
Copertina flessibile, Label: VDM Verlag, VDM Verlag, Produktgruppe: Libro, Publiziert: 2009-09-18, Studio: VDM Verlag.
5
Effect of Risk Disclosures on Prescription Dr . 9783639197556 | dpd Versand
DE NWISBN: 9783639197556 bzw. 3639197550, in Deutsch, VDM Verlag Dr. Müller, Saarbrücken, Deutschland, neu.
Lieferung aus: Deutschland, Lieferart: Free, Lieferung: Weltweit, Artikelstandort: 37574 Einbeck,Deutschland, Versandkostenfrei.
Von Händler/Antiquariat, aha-buch - AHA-BUCH.
Festpreisangebot.
Von Händler/Antiquariat, aha-buch - AHA-BUCH.
Festpreisangebot.
Lade…